Functional roles of CD26 / DPP4 in bleomycin‐induced pulmonary fibrosis
Physiological Reports · 2023
DOI: 10.14814/phy2.15645 ↗At a glance
Journal article in Physiological Reports, 2023. Written by Yu Koyanagi and 10 co-authors. Institution: Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan. Major MEDLINE topics: Pulmonary Fibrosis. Cited 6 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY 4.0). Funded by: Japan Agency for Medical Research and Development.
Abstract (original language)
The pathogenesis of pulmonary fibrosis involves complex interplay between cell types and signaling pathways. Recurrent alveolar epithelial injury can occur during pulmonary inflammation, causing dysregulation of epithelial repair. Dysregulated repair interacts with mesenchymal, inflammatory, and endothelial cells to trigger fibroblast‐to‐myofibroblast activation. CD26/dipeptidyl peptidase‐4 (DPP4) is a type II membrane protein mediating pleiotropic effect. However, the mechanistic role of CD26/DPP4 in pulmonary fibrosis remains unclear. In this study, we aimed to characterize Dpp4 deficiency in a mouse bleomycin (BLM)‐induced pulmonary fibrosis model and in cell culture systems of human lung fibroblasts (HLFs). Dpp4 knockout ( Dpp4 KO) mouse lungs exhibited lower Ashcroft scale indices, collagen content, and numbers of fibroblasts and myofibroblasts compared with those in C57BL/6 wild‐type (WT) mice. Upregulation of Tgfb1 and Tgfb2 mRNA levels in the lungs after BLM treatment was lower in Dpp4 KO mice compared with those in WT mice. Although TGF‐β‐driven endothelial‐to‐mesenchymal transition (EndMT) has been implicated as one of the mechanisms of pulmonary fibrosis, a number of partial EndMT cells in lungs did not differ between Dpp4 KO mice and WT mice. The proliferation capacity and mRNA levels of COL1A1 , a collagen deposition‐related gene, in cultured HLFs were suppressed in DPP4 small interfering RNA‐treated cells. This study indicates that the genetic deficiency of DPP4 has protective effects against BLM‐induced pulmonary fibrosis, partly through the reduction in TGF‐β expression and inhibition of fibroblast activation in the lung. Our study suggests that CD26/DPP4 inhibition is a potential therapeutic strategy for pulmonary fibrosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Department of Biomedical Science, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
- Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
- Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.
ORCID profiles: Takeshi Kawasaki
Funding
- Japan Agency for Medical Research and Development
Cite
APA
Koyanagi, Y., Kawasaki, T., Kasuya, Y., Hatano, R., Sato, S., Takahashi, Y., Ohnuma, K., Morimoto, C., Dudek, S. M., Tatsumi, K., & Suzuki, T. (2023). Functional roles of CD26 / DPP4 in bleomycin‐induced pulmonary fibrosis. Physiological Reports. https://doi.org/10.14814/phy2.15645
Vancouver
Koyanagi Y, Kawasaki T, Kasuya Y, Hatano R, Sato S, Takahashi Y, et al. Functional roles of CD26 / DPP4 in bleomycin‐induced pulmonary fibrosis. Physiological Reports. 2023. doi:10.14814/phy2.15645
BibTeX
@article{Koyanagi2023,
author = {Koyanagi, Yu and Kawasaki, Takeshi and Kasuya, Yoshitoshi and Hatano, Ryo and Sato, Shun and Takahashi, Yukiko and Ohnuma, Kei and Morimoto, Chikao and Dudek, Steven M and Tatsumi, Koichiro and Suzuki, Takuji},
title = {Functional roles of CD26 / DPP4 in bleomycin‐induced pulmonary fibrosis},
journal = {Physiological Reports},
year = {2023},
doi = {10.14814/phy2.15645}
}
EUVIMED